Hosted on MSN
Where the blockbuster weight loss drug market stands today — and what’s coming next
Eli Lilly's diabetes drug Mounjaro is viewed as a better treatment than Novo Nordisk's Ozempic, he noted. Real-world data and a head-to-head clinical trial have shown that Eli Lilly's obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback